If Vivek Kopparthi had his way, each community in developing countries around the world would have one of his devices. The co-founder and CEO of NeoLight, an Arizona-based healthcare startup, believes his company’s backpack-sized device can significantly improve the survival rates of infants, particularly those who are afflicted with jaundice.
The concept behind this startup is strikingly straightforward. The treatment involves phototherapy, which basically uses targeted amounts of light to break down excess bilirubin molecules into water-soluble isomers that are then safely excreted by the body.
###
NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.
